Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations.
about
Ubiquitin is covalently attached to the p6Gag proteins of human immunodeficiency virus type 1 and simian immunodeficiency virus and to the p12Gag protein of Moloney murine leukemia virusEfficient incorporation of HLA class II onto human immunodeficiency virus type 1 requires envelope glycoprotein packagingThe double-stranded RNA-binding protein Staufen is incorporated in human immunodeficiency virus type 1: evidence for a role in genomic RNA encapsidationA human nuclear shuttling protein that interacts with human immunodeficiency virus type 1 matrix is packaged into virions.Barrier-to-autointegration factor BAF binds p55 Gag and matrix and is a host component of human immunodeficiency virus type 1 virionsVacuolar protein sorting pathway contributes to the release of Marburg virusVirus entry, assembly, budding, and membrane raftsSpecific incorporation of heat shock protein 70 family members into primate lentiviral virionsTargeted infection of HIV-1 Env expressing cells by HIV(CD4/CXCR4) vectors reveals a potential new rationale for HIV-1 mediated down-modulation of CD4Involvement of claudin-7 in HIV infection of CD4(-) cells.Paracrine Signaling by Extracellular Vesicles via OsteoblastsMicrovesicles and viral infectionFatty acid synthase is up-regulated during hepatitis C virus infection and regulates hepatitis C virus entry and productionExosomes and Their Role in the Life Cycle and Pathogenesis of RNA VirusesThe microvesicle component of HIV-1 inocula modulates dendritic cell infection and maturation and enhances adhesion to and activation of T lymphocytesObstacles and opportunities in the functional analysis of extracellular vesicle RNA - an ISEV position paperPhysiological levels of virion-associated human immunodeficiency virus type 1 envelope induce coreceptor-dependent calcium flux.Ectopic ATP synthase facilitates transfer of HIV-1 from antigen-presenting cells to CD4(+) target cells.Highly efficient concentration of lenti- and retroviral vector preparations by membrane adsorbers and ultrafiltration.Three isoforms of cyclophilin A associated with human immunodeficiency virus type 1 were found by proteomics by using two-dimensional gel electrophoresis and matrix-assisted laser desorption ionization-time of flight mass spectrometry.Proteomic and biochemical analysis of purified human immunodeficiency virus type 1 produced from infected monocyte-derived macrophages.Chloroquine modulates HIV-1-induced plasmacytoid dendritic cell alpha interferon: implication for T-cell activation.Cyanovirin-N binds to gp120 to interfere with CD4-dependent human immunodeficiency virus type 1 virion binding, fusion, and infectivity but does not affect the CD4 binding site on gp120 or soluble CD4-induced conformational changes in gp120.In-solution virus capture assay helps deconstruct heterogeneous antibody recognition of human immunodeficiency virus type 1Dendritic cells from HIV-1 infected individuals are less responsive to toll-like receptor (TLR) ligands.Cells with high cyclophilin A content support replication of human immunodeficiency virus type 1 Gag mutants with decreased ability to incorporate cyclophilin AT cells expressing activated LFA-1 are more susceptible to infection with human immunodeficiency virus type 1 particles bearing host-encoded ICAM-1Human immunodeficiency virus type 1 attachment to HeLa CD4 cells is CD4 independent and gp120 dependent and requires cell surface heparans.Inactivation of human immunodeficiency virus type 1 infectivity with preservation of conformational and functional integrity of virion surface proteins.Containment of simian immunodeficiency virus infection: cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatmentInvolvement of the cytoplasmic domain of the hemagglutinin-neuraminidase protein in assembly of the paramyxovirus simian virus 5Association of Nef with the human immunodeficiency virus type 1 core.Partial activation and induction of apoptosis in CD4(+) and CD8(+) T lymphocytes by conformationally authentic noninfectious human immunodeficiency virus type 1.Differential incorporation of CD45, CD80 (B7-1), CD86 (B7-2), and major histocompatibility complex class I and II molecules into human immunodeficiency virus type 1 virions and microvesicles: implications for viral pathogenesis and immune regulationHuman immunodeficiency virus type 1 Vif protein is packaged into the nucleoprotein complex through an interaction with viral genomic RNA.Effect of the cytoplasmic domain of the simian immunodeficiency virus envelope protein on incorporation of heterologous envelope proteins and sensitivity to neutralization.Modulation of HIV-1 infectivity by MAPK, a virion-associated kinase.Regulation of TNF-related apoptosis-inducing ligand on primary CD4+ T cells by HIV-1: role of type I IFN-producing plasmacytoid dendritic cells.Virus maturation by budding.Endocytosis of HIV-1 activates plasmacytoid dendritic cells via Toll-like receptor-viral RNA interactions
P2860
Q24523226-7F9CEFEA-3EFA-40B9-A326-D609FA4E5BEBQ24524821-157B94B4-B3BA-4566-8B97-721B7CA97211Q24525207-A809645D-B37C-486C-89DC-D6908EC1E537Q24527227-730D9474-356B-476E-A9E9-CD3C31C6573BQ24628754-57EAF549-DE08-49E8-9665-6B7629B6F220Q24652215-303407A8-3286-4004-B15B-CCA9B0E97D36Q24673161-285B789E-BB88-4761-AEFD-680EEB3A11F8Q24674076-2569650C-88CB-481F-AE29-75984309044AQ25257643-8CDD4387-2469-48B0-9FC4-947A7008E5D8Q25257657-2BCC7553-F88B-4FF8-8DE8-9F2BF4E03DCCQ26739740-E1EECB8A-DB82-43A7-885A-6B864D254111Q26823408-F33D3F84-FCD1-4E0A-90EF-75D9F2CC147DQ27487550-D03291B1-D83C-4934-8202-ECC9E2C7B80BQ28084897-52C62709-6267-402D-87F9-DD7EAFA14551Q28534504-9812DB10-AD04-4800-A7EC-66C3FA548260Q30360749-0D3EF268-A394-4996-8F15-605F37458533Q30478990-6FCF266D-7296-4BF5-952A-2DCA2F4F13DCQ30524180-864A483D-4913-483C-AA45-8F83DEC04225Q31014077-213CE01D-21B1-41B9-BDC2-992F8E743CA4Q31107472-189DF8C6-4C8C-4FE4-A636-11EDC93FD987Q33255758-A0F52711-626D-4507-9CB1-97AD54AEB30AQ33613674-C7BEFD6F-CEDF-40E1-8CA9-B680EE739762Q33648180-E1B1F853-142F-4079-8310-F950D3A1BB64Q33725718-8180B230-7F42-4AA2-867B-B0973F1D1EA3Q33725882-A5EFBD02-7446-4636-B6D5-F72E5F75F9F8Q33781971-1CD1FDD5-45FC-4846-B8FD-2BA80C7DEB9CQ33782387-390D79AE-6EB8-4E9D-91F7-0AD60DA4CFA7Q33782608-708D75C2-61D0-476D-856B-443B73D05069Q33784777-CB620D4D-C819-4A26-8C5D-1A755ED4429AQ33799700-2560BAD7-DC5E-4F22-9EAB-A6BF9672557AQ33820965-18D5F48F-D805-49C0-B7CA-8B7CBD273B32Q33821376-B9E87476-AB9F-49E9-8E9B-6D48B77F657BQ33836036-D7CDCFF9-E608-4715-8D95-C13B4A5BF95EQ33842620-3BB89996-1DB8-4299-9299-4B1E56B42850Q33852465-47A27D26-506D-49C9-BAA3-401E0F61399FQ33873610-18AE882C-E837-47C9-8C5D-622B37FFBBFFQ33888794-13ED81D6-A3B0-4CD1-9D7D-7EB9E7F78146Q34014711-F5E70B19-2BDF-43F5-8B59-AE063CCD8C2DQ34068037-9BC3F20A-E729-46EA-850C-E2010A678AF5Q34078687-AF445DF9-BDB0-4525-BD6F-C1776D253A8B
P2860
Microvesicles are a source of contaminating cellular proteins found in purified HIV-1 preparations.
description
1997 nî lūn-bûn
@nan
1997 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1997 թվականի մարտին հրատարակված գիտական հոդված
@hy
1997年の論文
@ja
1997年論文
@yue
1997年論文
@zh-hant
1997年論文
@zh-hk
1997年論文
@zh-mo
1997年論文
@zh-tw
1997年论文
@wuu
name
Microvesicles are a source of ...... n purified HIV-1 preparations.
@ast
Microvesicles are a source of ...... n purified HIV-1 preparations.
@en
Microvesicles are a source of ...... n purified HIV-1 preparations.
@nl
type
label
Microvesicles are a source of ...... n purified HIV-1 preparations.
@ast
Microvesicles are a source of ...... n purified HIV-1 preparations.
@en
Microvesicles are a source of ...... n purified HIV-1 preparations.
@nl
prefLabel
Microvesicles are a source of ...... n purified HIV-1 preparations.
@ast
Microvesicles are a source of ...... n purified HIV-1 preparations.
@en
Microvesicles are a source of ...... n purified HIV-1 preparations.
@nl
P2093
P356
P1433
P1476
Microvesicles are a source of ...... n purified HIV-1 preparations.
@en
P2093
Bess JW Jr
Gorelick RJ
Henderson LE
P304
P356
10.1006/VIRO.1997.8499
P407
P577
1997-03-01T00:00:00Z